Walder Wyss advised Swiss energy provider Repower, in connection with the sale of its Plug’n Roll business to Avia Volt Suisse. Plug’n Roll serves over 24,600 registered users with 2,345 charging points, of which over 500 are public. The company Headquartered in Poschiavo, Switzerland, Repower operates as an electricity producer, distribution grid operator and energy […]
Wenger Vieli advised Swiss cleantech startup DePoly in connection with its seed financing round extension, reaching a total fundraise amount of USD 23m. The proceeds from the operation will support the inauguration of DePoly’s 500
MME advised medtech buy-and-build platform Healthcare Holding Schweiz on its acquisition of CDP Swiss and Aesthetic Bedarf. The company Headquartered in Baar, Zug, Healthcare Holding Schweiz focuses on strategic acquisitions, partnerships, and organic expansion initiatives
Kellerhals Carrard advised Basel-based CGC Genomics Consults on all legal aspects of their pre-seed financing round. Pursuant to the transaction, the Swiss startup secured approximately EUR 1.7 million. The context Several impact and health-tech investors led
Bär & Karrer advised Foconis, a portfolio company of Main Capital Partners, on its acquisition of MACD and its subsidiaries. The parties Headquartered in Urdorf, Zurich, MACD is a provider of electronic trading systems,
Bär & Karrer advised Sandberg Capital and ARX Equity Partners in connection with their acquisition of a majority stake in Travelnode, the holding company of Phobs, a software provider for the hospitality sector in
Niederer Kraft Frey (NKF) advised DCC plc in connection with the sale of DCC Healthcare to HealthCo, an investment subsidiary of funds whether managed, advised – or both – by Investindustrial. Pursuant to the proposed transaction, DCC
Banking & Finance Baker McKenzie advised UBS Switzerland and a syndicate of Swiss banks on the conclusion of a syndicated credit facility agreement for Mercedes-Benz Automobil (Merbag). The proceeds of the facility in question will
Kellerhals Carrard advised Burgdorf-based TecMed as lead counsel on the company’s acquisition of Ypsomed’s diabetes care business for CHF 420 million, including earn-out. Moreover, Walder Wyss represented the selling part throughout the transaction. Closing
Lenz & Staehelin is advising Baloise as lead counsel on its merger with Helvetia, which is represented by Walder Wyss. The two Swiss composite insurance groups will join forces, thus combining a business volume of
